| An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes (NCT00960076) | AstraZeneca | 2009-08-01 |
| Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36) (NCT00970268) | AstraZeneca | 2009-08-01 |
| Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy (NCT00836160) | AstraZeneca | 2009-08-01 |
| Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients (NCT00972244) | AstraZeneca | 2009-08-01 |
| To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension (NCT00944489) | AstraZeneca | 2009-08-01 |
| Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments (NCT01086319) | AstraZeneca | 2009-08-01 |
| AZD5985 Single Ascending Dose Study (NCT00967356) | AstraZeneca | 2009-08-01 |
| AZD2066 Neuropathic Pain - Mechanical Hypersensitivity (NCT00939094) | AstraZeneca | 2009-08-01 |
| AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects (NCT00970775) | AstraZeneca | 2009-08-01 |
| Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients (NCT00922025) | AstraZeneca | 2009-08-01 |
| Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 (NCT00973076) | AstraZeneca | 2009-08-01 |
| A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa (NCT01000740) | AstraZeneca | 2009-08-01 |
| Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305 (NCT00957437) | AstraZeneca | 2009-08-01 |
| Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration (NCT00940641) | AstraZeneca | 2009-08-01 |
| Symbicort SMART Satisfaction From Patient Perspective 2009 (NCT00946452) | AstraZeneca | 2009-08-01 |
| Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg (NCT00918138) | AstraZeneca | 2009-08-01 |
| Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers (NCT00945178) | AstraZeneca | 2009-08-01 |
| AZD5423 Single Ascending Dose Study (NCT00963183) | AstraZeneca | 2009-08-01 |
| Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients (NCT00960349) | AstraZeneca | 2009-08-01 |
| Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects (NCT00935467) | AstraZeneca | 2009-07-01 |
| Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients (NCT00936221) | AstraZeneca | 2009-07-01 |
| A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended (NCT00922090) | AstraZeneca | 2009-07-01 |
| Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus (NCT00935532) | AstraZeneca | 2009-07-01 |
| AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects (NCT00935025) | AstraZeneca | 2009-07-01 |
| Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (NCT00884143) | AstraZeneca | 2009-07-01 |
| A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium (NCT00949975) | AstraZeneca | 2009-07-01 |
| Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects (NCT00930865) | AstraZeneca | 2009-07-01 |
| Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ (NCT00914342) | AstraZeneca | 2009-07-01 |
| Non-Interventional Study of Zoladex in Endometriosis (NCT00938496) | AstraZeneca | 2009-07-01 |
| Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia (NCT00939341) | AstraZeneca | 2009-07-01 |
| Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia (NCT00934726) | AstraZeneca | 2009-07-01 |
| Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers (NCT00940212) | AstraZeneca | 2009-07-01 |
| Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study (NCT00963144) | AstraZeneca | 2009-07-01 |
| A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses (NCT00935662) | AstraZeneca | 2009-07-01 |
| Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects (NCT00953888) | AstraZeneca | 2009-07-01 |
| Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients (NCT00952588) | AstraZeneca | 2009-07-01 |
| A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects (NCT00917267) | AstraZeneca | 2009-07-01 |
| AZD7325 Japan Multiple Ascending Dose (MAD) Study (NCT00945425) | AstraZeneca | 2009-07-01 |
| Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects (NCT00908271) | AstraZeneca | 2009-07-01 |
| Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study (NCT00927420) | AstraZeneca | 2009-07-01 |
| Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (NCT00931320) | AstraZeneca | 2009-07-01 |
| Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine (NCT00937664) | AstraZeneca | 2009-07-01 |
| Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) (NCT00960791) | AstraZeneca | 2009-07-01 |
| AZD2066 Cocktail Study (NCT00930306) | AstraZeneca | 2009-06-01 |
| Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241 (NCT00914303) | AstraZeneca | 2009-06-01 |
| The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease (NCT00939211) | AstraZeneca | 2009-06-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) (NCT00899470) | AstraZeneca | 2009-06-01 |
| Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males (NCT00930215) | AstraZeneca | 2009-06-01 |
| Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients (NCT00919607) | AstraZeneca | 2009-06-01 |
| Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression (NCT00926393) | AstraZeneca | 2009-06-01 |
| Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B) (NCT00897390) | AstraZeneca | 2009-06-01 |
| Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) (NCT00900627) | AstraZeneca | 2009-06-01 |
| Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients (NCT00921804) | AstraZeneca | 2009-06-01 |
| AZD6088 Single Ascending Dose Study (NCT00931541) | AstraZeneca | 2009-06-01 |
| ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer (NCT00929162) | AstraZeneca | 2009-06-01 |
| Renal Mechanism of Action/Splay vs. TmG (NCT00726505) | AstraZeneca | 2009-06-01 |
| Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC) (NCT00926731) | AstraZeneca | 2009-06-01 |
| Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (NCT00928629) | AstraZeneca | 2009-06-01 |
| Arimidex Therapy Compliance Electronic Monitoring System (NCT00936442) | AstraZeneca | 2009-06-01 |
| Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure (NCT00925470) | AstraZeneca | 2009-06-01 |
| Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00929708) | AstraZeneca | 2009-06-01 |
| Adult Bipolar Mania (NCT00931723) | AstraZeneca | 2009-06-01 |
| AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations (NCT00918398) | AstraZeneca | 2009-06-01 |
| Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects (NCT00904176) | AstraZeneca | 2009-06-01 |
| European Study of Cardiovascular Risk (NCT00882336) | AstraZeneca | 2009-05-01 |
| Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305 (NCT00915356) | AstraZeneca | 2009-05-01 |
| Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects (NCT00901290) | AstraZeneca | 2009-05-01 |
| Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg (NCT00919477) | AstraZeneca | 2009-05-01 |
| Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases (NCT00910728) | AstraZeneca | 2009-05-01 |
| Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control (NCT00918879) | AstraZeneca | 2009-05-01 |
| Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus (NCT00885378) | AstraZeneca | 2009-05-01 |
| C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS) (NCT00921752) | AstraZeneca | 2009-05-01 |
| A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder (NCT00888264) | AstraZeneca | 2009-05-01 |
| Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status (NCT00912743) | AstraZeneca | 2009-05-01 |
| Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy (NCT00857584) | AstraZeneca | 2009-05-01 |
| Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low) (NCT00882128) | AstraZeneca | 2009-05-01 |
| Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand (NCT00800241) | AstraZeneca | 2009-05-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043 (NCT00918515) | AstraZeneca | 2009-05-01 |
| Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease (NCT00894426) | AstraZeneca | 2009-05-01 |
| AZD9056 Relative Bioavailability Study (NCT00908934) | AstraZeneca | 2009-05-01 |
| Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand (NCT00800904) | AstraZeneca | 2009-05-01 |
| Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E (NCT00907400) | AstraZeneca | 2009-05-01 |
| To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients (NCT00916604) | AstraZeneca | 2009-05-01 |
| Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (NCT00891124) | AstraZeneca | 2009-05-01 |
| of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (NCT00925717) | AstraZeneca | 2009-05-01 |
| Quality Project to Evaluate and Validate the FAST-O Rating Scale (NCT00913731) | AstraZeneca | 2009-05-01 |
| AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects (NCT00912353) | AstraZeneca | 2009-05-01 |
| Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users (NCT00902772) | AstraZeneca | 2009-05-01 |
| Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey (NCT00916513) | AstraZeneca | 2009-05-01 |
| AZD0837 Extended Release (ER) Japan Study (NCT00904800) | AstraZeneca | 2009-05-01 |
| 10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI) (NCT00885612) | AstraZeneca | 2009-05-01 |
| A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients (NCT00920608) | AstraZeneca | 2009-05-01 |
| AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients (NCT00890825) | AstraZeneca | 2009-04-20 |
| Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446 (NCT00902993) | AstraZeneca | 2009-04-01 |
| Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes (NCT00831779) | AstraZeneca | 2009-04-01 |
| Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients (NCT00886366) | AstraZeneca | 2009-04-01 |
| Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients (NCT01164397) | AstraZeneca | 2009-04-01 |
| Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity (NCT00884247) | AstraZeneca | 2009-04-01 |
| AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects (NCT00886756) | AstraZeneca | 2009-04-01 |
| Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837 (NCT00878618) | AstraZeneca | 2009-04-01 |